Breastfeeding and Leukemia: How Nursing May Lower Childhood Cancer Risk
Understand the intricate link between breastfeeding and childhood leukemia, including risk factors, research, and practical guidance for parents.

Breastfeeding and Leukemia: Understanding the Connection
Breastfeeding, or chestfeeding, is widely recognized for its numerous benefits to both infants and birthing parents. Beyond its established role in nutrition and immunity, emerging research suggests that breastfeeding may play a significant role in lowering the risk of childhood leukemia—the most common cancer in children and adolescents. This article explores the relationship between breastfeeding and leukemia risk, investigates the science behind this association, discusses the practicalities of breastfeeding after a leukemia diagnosis, and examines alternative feeding options and other risk factors.
What Is Childhood Leukemia?
Leukemia is a type of blood cancer that starts in the bone marrow and leads to the overproduction of abnormal white blood cells. There are two main types seen in children:
- Acute Lymphocytic Leukemia (ALL): The most common form in children.
- Acute Myeloid Leukemia (AML): Less common, but still significant.
Chronic forms of leukemia are rare among children. Although childhood leukemia is considered rare overall, it is the biggest group of pediatric cancers, which makes understanding its risk factors all the more important.
Can Breastfeeding Reduce the Risk of Childhood Leukemia?
Multiple studies and reviews indicate that breastfeeding for at least 6 months may lower a child’s risk of developing leukemia. The reduction in risk found in research varies, but a major review reported a 20% lower risk of childhood leukemia among those breastfed for 6 months or more compared to those who were not breastfed or were breastfed for shorter periods.
The duration of breastfeeding appears relevant as well. In a large retrospective case-control study conducted in China, breastfeeding for 7–9 months was associated with the strongest protective effect against childhood leukemia.
How Does Breastfeeding Offer Protection?
The precise mechanisms are not fully understood, but researchers propose several key theories:
- Transfer of antibodies: Breast milk is rich in immunoglobulins, which help arm the infant’s immune system against infections.
- Immune system development: Breastfeeding shapes the development and regulation of the infant’s immune responses.
- Reduced inflammation: Compounds in breast milk help lower systemic inflammation, which may reduce the risk of mutations and cancerous changes.
- Promotion of a healthy gut microbiome: Breast milk acts as a prebiotic, fostering beneficial gut bacteria that further train and support immune function.
- Prevention of infection: By reducing infections, breastfeeding may limit immune system overactivation, a phenomenon linked to leukemia in some studies.
- Bioactive components: Substances like lactoferrin and the protein-lipid complex a-lactalbumin in breast milk may induce cell death in abnormal or potentially cancerous cells.
Notably, these protective actions are not limited to leukemia but also contribute to lower risk for several other childhood illnesses.
Breastfeeding Duration: How Long Is Optimal?
Evidence supports that longer breastfeeding confers greater protection against leukemia. The recommended minimum is 6 months of exclusive breastfeeding. Some studies, especially the large case-control study in China, suggest the 7–9 month period is associated with the most substantial reduction in risk, while further extended periods did not always add additional benefit and sometimes saw a waning protective effect, possibly due to changes in breast milk composition over time.
It’s important to note that cultural, economic, and social factors may influence breastfeeding duration in different countries. Personal and medical circumstances can also affect how long parents are able to breastfeed.
Other Benefits of Breastfeeding
Protection against childhood leukemia is just one aspect of breastfeeding’s health impact. Additional advantages include:
- Stronger immune function and fewer infections (respiratory, ear, gastrointestinal)
- Optimal nutrient profile tailored to infant needs
- Lower risk of chronic conditions such as obesity and type 2 diabetes later in life
- Bonding and psychological benefits for both infant and parent
- Reduced risk of certain cancers for breastfeeding parents
These advantages add further value to breastfeeding whenever possible, though formula feeding remains a safe and healthy option when necessary.
The Science Behind Breastfeeding and Cancer Protection
What makes breast milk such a powerful ally in disease prevention, including leukemia? A closer look reveals a complex composition of nutrients and bioactive substances with the following functions:
- Antibodies (Immunoglobulins): Defend against pathogens in the early months when an infant’s own immune system is immature.
- Lactoferrin: Inhibits growth of bacteria and some cancer cells.
- Oligosaccharides: Support a healthy gut environment and immune training.
- Human Milk Oligosaccharides (HMOs): May influence inflammation and immune signaling.
- Hormones and growth factors: Regulate development and may help control abnormal cell growth.
- A-lactalbumin: In altered (acidic) environments can form complexes that induce cell death (apoptosis) in tumor cells.
These components collectively create a dynamic defense system, reinforcing the body’s ability to prevent diseases, including but not limited to childhood cancers.
Can You Breastfeed If You Have Leukemia?
For parents who are diagnosed with leukemia, the decision to breastfeed is highly individualized and depends on several factors:
- Type of treatment: Many cancer drugs—including chemotherapy, targeted therapy, and immunotherapy—can pass into breast milk and may be harmful for infants.
- Type and duration of therapy: For example, radiation therapy near the breasts can impair milk production while other forms of radiation may not directly affect breastfeeding ability.
- Overall health status: Treatment-induced fatigue or compromised health may also make breastfeeding more challenging.
- Individual and infant circumstances: Other medical issues—in parent or child—may also influence this decision.
Certain conditions mean breastfeeding is not recommended:
- If the infant has classic galactosemia (an inherited disorder)
- If the parent is HIV positive
- When the parent is on medications known to be harmful to the infant through breast milk
Consulting a healthcare professional—such as an oncologist, pediatrician, or lactation consultant—is essential for parents with leukemia who wish to consider breastfeeding. Medical teams will review the safety and help balance potential benefits and risks.
Does Formula Feeding Increase the Risk of Leukemia?
Infant formula itself does not cause leukemia. However, shorter duration of breastfeeding or not breastfeeding at all is associated in some studies with a higher risk of leukemia compared to longer-term breastfeeding. The exact reason is not fully established, but one area of research involves differences in the gut microbiome and essential fatty acids:
- Altered gut microbiome: Formula changes the composition of gut bacteria, which may affect immune function and risk for various diseases, including leukemia.
- Fatty acid content: Some studies have found higher levels of linoleic and linolenic acid in formulas compared to breast milk and an association between higher levels in newborns and later development of leukemia.
Nevertheless, parents unable or choosing not to breastfeed should know infant formulas are safe and carefully regulated, providing complete nutrition. The decision between breastfeeding and formula feeding depends on medical, personal, and practical factors. Healthcare professionals can help select an appropriate formula if needed.
Childhood Leukemia Risk Factors Beyond Feeding Choices
While breastfeeding appears protective, other risk factors for childhood leukemia have been identified. Many of these are not modifiable, but understanding them may help guide future research and individual risk assessment:
- Genetic factors (heritable mutations, family history of cancers)
- Maternal age at birth
- Maternal exposures during pregnancy (such as smoking, some medications, and use of hair dye)
- History of abortion and certain reproductive factors
- Parental use of birth control pills before pregnancy (studied in some populations)
- Environmental exposures (such as pesticides, radiation, benzene)
Most children diagnosed with leukemia do not have clearly identifiable risk factors, so prevention strategies focus on broad health promotion and early detection.
Overcoming Obstacles to Breastfeeding
Parents may face several barriers to breastfeeding, ranging from medical to practical and societal:
- Medical conditions (parental illnesses, medications, infant health problems)
- Lactation difficulties (latch issues, low supply, pain)
- Employment and social support
- Cultural norms and perceptions
Parents experiencing obstacles are encouraged to seek help from healthcare professionals, lactation consultants, and support networks. Many communities offer lactation support groups, hotlines, and online resources for additional assistance.
Making the Best Feeding Choice for Your Family
No single feeding choice works for every family. Parents should weigh the available evidence, their own health circumstances, practicalities, and preferences in collaboration with their healthcare team. Breastfeeding offers many well-documented benefits, including a lower risk for childhood leukemia, but formula feeding also supports healthy growth and development for babies when breastfeeding is not possible or preferred.
Your pediatrician or primary care doctor is the best source for tailored advice on feeding choices and infant health.
FAQ: Frequently Asked Questions about Breastfeeding and Leukemia
Does breastfeeding completely prevent childhood leukemia?
No. Breastfeeding can lower the risk, but it does not eliminate it entirely. Most children diagnosed with leukemia do not have any known modifiable risk factors.
Is formula unsafe for my baby?
No. Infant formulas are rigorously tested and regulated to provide complete nutrition and are a healthy alternative when breastfeeding is not possible or preferred.
How long should I breastfeed to get the cancer-protective benefit?
Studies recommend at least 6 months of exclusive breastfeeding for optimal protection. Some data suggest a 7–9 month duration may be ideal, but any period of breastfeeding can be beneficial.
Can breastfeeding help if my child has already been diagnosed with leukemia?
While breastfeeding supports immune health, there is no evidence that it treats active leukemia. For families affected by cancer, feeding choices should be guided by your child’s oncologist and care team.
Is it ever unsafe to breastfeed while being treated for cancer?
Yes. Many cancer treatments (chemotherapy, targeted therapy, immunotherapy) can pass through breast milk and pose risks to infants. Discuss all medications and your health status with your doctor before breastfeeding while undergoing treatment.
Key Takeaways
- Breastfeeding appears to lower the risk of childhood leukemia, especially when continued for 6 months or longer.
- Breast milk’s unique composition supports immune function and healthy development.
- The decision to breastfeed or use formula depends on individual circumstances, health, and personal preference.
- Families facing leukemia diagnoses should consult medical experts about safe feeding options.
Supporting optimal nutrition and the best possible start in life for all children remains the shared goal—whichever feeding route you choose. Prioritize communication with healthcare providers to address questions and challenges as they arise.
References
- https://www.healthline.com/health/leukemia/breastfeeding-and-leukemia
- https://pmc.ncbi.nlm.nih.gov/articles/PMC6116700/
- https://www.medicalnewstoday.com/articles/breastfeeding-and-leukemia
- https://www.healthline.com/health/leukemia
- https://www.ncbi.nlm.nih.gov/books/n/usdanebfl/ch1/
- https://academic.oup.com/jnci/article/91/20/1765/2543871
Read full bio of Sneha Tete